Recently by Christina M. Markus
FDA Publishes Draft Guidance For Industry On Presenting Risk Information During Prescription Drug And Medical Device Promotion
FDA Requests Public Comments By August 25, 2009 In response to industry requests for better insight into how FDA evaluates promotional materials for prescription drugs and medical devices for compliance with statutory and regulatory requirements, FDA issued a Draft Guidance document on May 26...
Read More